Development of a GC-MS/MS method to quantify 120 gut microbiota-derived metabolites
Analytical and Bioanalytical Chemistry · 2026-02 · 418 (4) · 1035-1054
DOI: 10.1007/s00216-025-06256-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical and Bioanalytical Chemistry, online erschienen am 15.12.2025. Verfasst von Nikita Denisov und 6 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Systems Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Gas Chromatography-Mass Spectrometry, Tandem Mass Spectrometry, Volatile Organic Compounds. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung, European Research Council, European Molecular Biology Laboratory (EMBL).
Abstract (Originalsprache)
The gut microbiota produces metabolites that are important for host physiology and have critical roles in the development of diseases, such as metabolic disorders, cardiovascular diseases, and cancer. Here, we developed a gas chromatography-coupled tandem mass spectrometry (GC-MS/MS) method for the quantification of 120 volatile and semi-volatile compounds produced by gut bacteria, including short-chain fatty acids, indols, nucleotides, organic acids, and amino acid derivatives. The method is based on multiple-reaction-monitoring (MRM) of each analyte and their respective isotopically labeled internal standard, enabling absolute metabolite quantification between 0.45 pmol and 1 nmol. Applying the method to different tissue samples from germfree and conventionally colonized mice, we illustrate the ability to quantify microbiota-produced metabolites in different sample matrices—plasma, liver, feces, and intestinal content—and at different concentrations. Lastly, we demonstrate that this protocol is capable of quantifying microbiota-derived metabolites in stool samples stored in DNA stabilization buffers that are typically used in sequencing-based microbiome studies. Altogether, the developed GC-MS/MS method adds a valuable analytical tool to quantify microbiota-host metabolic interactions. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Systems Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
- Center for Infectious Diseases (LUCID), Leiden University, Leiden University Medical Center (LUMC), Leiden, Netherlands.
- Molecular Systems Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany. michael.zimmermann@embl.de.
Förderung
- Bundesministerium für Bildung und Forschung
- European Research Council
- European Molecular Biology Laboratory (EMBL)
Zitieren
APA
Denisov, N., Springer, F., Brauer-Nikonow, A., Maftei, G., Zeller, G., Selegato, D. M., & Zimmermann, M. (2026). Development of a GC-MS/MS method to quantify 120 gut microbiota-derived metabolites. Analytical and Bioanalytical Chemistry, 418(4), 1035-1054. https://doi.org/10.1007/s00216-025-06256-6
Vancouver
Denisov N, Springer F, Brauer-Nikonow A, Maftei G, Zeller G, Selegato DM, et al. Development of a GC-MS/MS method to quantify 120 gut microbiota-derived metabolites. Analytical and Bioanalytical Chemistry. 2026;418(4):1035-1054. doi:10.1007/s00216-025-06256-6
BibTeX
@article{Denisov2026,
author = {Denisov, Nikita and Springer, Fabian and Brauer-Nikonow, Amber and Maftei, George and Zeller, Georg and Selegato, Denise Medeiros and Zimmermann, Michael},
title = {Development of a GC-MS/MS method to quantify 120 gut microbiota-derived metabolites},
journal = {Analytical and Bioanalytical Chemistry},
year = {2026},
volume = {418},
number = {4},
pages = {1035--1054},
doi = {10.1007/s00216-025-06256-6}
}
EUVIMED